Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development

被引:13
作者
Chan, R [1 ]
Hardy, WR [1 ]
Dankort, D [1 ]
Laing, MA [1 ]
Muller, WJ [1 ]
机构
[1] McMaster Univ, Dept Biol, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada
来源
DEVELOPMENT | 2004年 / 131卷 / 22期
关键词
Erbb2; tyrosine phosphorylation; knock-in; hypomorph;
D O I
10.1242/dev.01425
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have generated a series of Erbb2 cDNA knock-in animals to explore the role of signaling pathways coupled to Erbb2 during development. Although this knock-in allele was hypomorphic, expressing tenfold less Erbb2 protein than wild type, the knock-in animals were healthy. However, a further twofold reduction in Erbb2 levels in hemizygous knock-in animals resulted in perinatal lethality with defects in the innervation of the diaphragm. Genetic rescue of this hypomorph was accomplished by expression of the Erbb2-Y1028F mutant in a comparable knock-in allele. Interestingly, hemizygous Y1028F animals were viable with normal innervation of the diaphragm. Molecular analyses revealed that the Y1028F allele expressed higher levels of Erbb2 and that Y1028 promoted the turnover of the receptor. In addition, ablation of the Shc-binding site in Erbb2 (Y1227) resulted in subtle defects in the sensory nerves not observed in the other mutant erbb2 strains. Thus, we have established how Erbb2 levels may be modulated through development and that a minimum threshold level of Erbb2 is required.
引用
收藏
页码:5551 / 5560
页数:10
相关论文
共 47 条
[11]   Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation [J].
Dankort, DL ;
Wang, ZX ;
Blackmore, V ;
Moran, MF ;
Muller, WJ .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5410-5425
[12]   ABERRANT NEURAL AND CARDIAC DEVELOPMENT IN MICE LACKING THE ERBB4 NEUREGULIN RECEPTOR [J].
GASSMANN, M ;
CASAGRANDA, F ;
ORIOLI, D ;
SIMON, H ;
LAI, C ;
KLEIN, R ;
LEMKE, G .
NATURE, 1995, 378 (6555) :390-394
[13]   HETERODIMERIZATION OF THE ERBB-1 AND ERBB-2 RECEPTORS IN HUMAN BREAST-CARCINOMA CELLS - A MECHANISM FOR RECEPTOR TRANSREGULATION [J].
GOLDMAN, R ;
BENLEVY, R ;
PELES, E ;
YARDEN, Y .
BIOCHEMISTRY, 1990, 29 (50) :11024-11028
[14]   New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway [J].
Gu, HH ;
Maeda, H ;
Moon, JJ ;
Lord, JD ;
Yoakim, M ;
Nelson, BH ;
Neel, BG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) :7109-7120
[15]   INSECT CELL-EXPRESSED P180(ERBB3) POSSESSES AN IMPAIRED TYROSINE KINASE-ACTIVITY [J].
GUY, PM ;
PLATKO, JV ;
CANTLEY, LC ;
CERIONE, RA ;
CARRAWAY, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :8132-8136
[16]  
HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3
[17]   Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site tyr992 [J].
Holbrook, MR ;
O'Donnell, JB ;
Slakey, LL ;
Gross, DJ .
BIOCHEMISTRY, 1999, 38 (29) :9348-9356
[18]   THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER [J].
HYNES, NE ;
STERN, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3) :165-184
[19]   ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer [J].
Karunagaran, D ;
Tzahar, E ;
Beerli, RR ;
Chen, XM ;
GrausPorta, D ;
Ratzkin, BJ ;
Seger, R ;
Hynes, NE ;
Yarden, Y .
EMBO JOURNAL, 1996, 15 (02) :254-264
[20]   Receptor downregulation and multivesicular-body sorting [J].
Katzmann, DJ ;
Odorizzi, G ;
Emr, SD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :893-905